Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Medtronic
Cantor Fitzgerald
Moodys
McKesson
UBS
Harvard Business School

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,962,461

« Back to Dashboard

Summary for Patent: 5,962,461
Title: Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
Abstract:A liquid pharmaceutical composition is contemplated that comprises a pharmaceutically effective amount of a bitter tasting drug dissolved or dispersed in an aqueous medium that is free of ethanol. That aqueous medium consists essentially of water, about 5 to about 30 weight percent polyvinylpyrrolidone, about 35 to about 55 weight percent of a C.sub.3 -C.sub.6 polyol, about 0.01 to about 0.5 weight percent ammonium glycyrrhizinate and one or more flavorants. The liquid composition is transparent and has a pleasant taste. The bitter tasting drugs claimed herein are vitamin and mineral preparations, trimethoprim, and guaifenesin.
Inventor(s): Anaebonam; Aloysius O. (Burlington, MA), Clemente; Emmett (Manchester, MA), Fawzy; Abdel A. (Groton, MA)
Assignee: Ascent Pediatrics, Inc. (Billerica, MA)
Application Number:09/011,156
Patent Claim Types:
see list of patent claims
Composition; Delivery;

Drugs Protected by US Patent 5,962,461

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,962,461

PCT Information
PCT FiledAugust 07, 1997PCT Application Number:PCT/US97/14018
PCT Publication Date:February 12, 1998PCT Publication Number: WO98/05312

International Patents Family Members for US Patent 5,962,461

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 236624 ➤ Try a Free Trial
Australia 3913297 ➤ Try a Free Trial
Australia 727175 ➤ Try a Free Trial
Canada 2260852 ➤ Try a Free Trial
Germany 69720759 ➤ Try a Free Trial
Denmark 0938302 ➤ Try a Free Trial
European Patent Office 0938302 ➤ Try a Free Trial
Spain 2196355 ➤ Try a Free Trial
Japan 2000505093 ➤ Try a Free Trial
Japan 3778518 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Citi
Federal Trade Commission
Dow
US Department of Justice
Mallinckrodt
AstraZeneca
Colorcon
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot